Vincenzo Leuzzi

ORCID: 0000-0002-2314-6139
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Metabolism and Genetic Disorders
  • Mitochondrial Function and Pathology
  • Genetics and Neurodevelopmental Disorders
  • Diet and metabolism studies
  • Amino Acid Enzymes and Metabolism
  • Genetic Neurodegenerative Diseases
  • Folate and B Vitamins Research
  • Genomics and Rare Diseases
  • Muscle metabolism and nutrition
  • Biochemical and Molecular Research
  • Neurological disorders and treatments
  • DNA Repair Mechanisms
  • Fetal and Pediatric Neurological Disorders
  • Genomic variations and chromosomal abnormalities
  • Neonatal Health and Biochemistry
  • Genetic and Kidney Cyst Diseases
  • Lysosomal Storage Disorders Research
  • Biotin and Related Studies
  • RNA modifications and cancer
  • Glycogen Storage Diseases and Myoclonus
  • RNA regulation and disease
  • Advanced MRI Techniques and Applications
  • Neurogenetic and Muscular Disorders Research
  • Parkinson's Disease Mechanisms and Treatments
  • Neurological diseases and metabolism

Sapienza University of Rome
2016-2025

Policlinico Umberto I
2011-2023

Telethon Institute Of Genetics And Medicine
2022

University of Campania "Luigi Vanvitelli"
2022

University College London
2017-2022

National Hospital for Neurology and Neurosurgery
2022

University of L'Aquila
2022

University Medical Center Groningen
2021

Inserm
2003-2021

Université de Tours
2021

Tyrosine hydroxylase deficiency is an autosomal recessive disorder resulting from cerebral catecholamine deficiency. has been reported in fewer than 40 patients worldwide. To recapitulate all available evidence on clinical phenotypes and rational diagnostic therapeutic approaches for this devastating, but treatable, neurometabolic disorder, we studied 36 with tyrosine reviewed the literature. Based presenting neurological features, can be divided two phenotypes: infantile onset, progressive,...

10.1093/brain/awq087 article EN Brain 2010-04-29

Dopamine transporter deficiency syndrome due to SLC6A3 mutations is the first inherited dopamine 'transportopathy' be described, with a classical presentation of early infantile-onset progressive parkinsonism dystonia. In this study we have identified new cohort patients syndrome, including, most significantly, atypical later in childhood milder disease course. We report detailed clinical features, molecular genetic findings and vitro functional investigations undertaken for adult paediatric...

10.1093/brain/awu022 article EN cc-by Brain 2014-03-10

Abstract Background Ataxia Teleangiectasia [AT] is a rare neurodegenerative disease characterized by early onset ataxia, oculocutaneous teleangiectasias, immunodeficiency, recurrent infections, radiosensitivity and proneness to cancer. No therapies are available for this devastating disease. Recent observational studies in few patients showed beneficial effects of short term treatment with betamethasone. To avoid the characteristic side long-term administration steroids we developed method...

10.1186/1750-1172-9-5 article EN cc-by Orphanet Journal of Rare Diseases 2014-01-09

We collected data on 48 patients from 38 families with guanidinoacetate methyltransferase (GAMT) deficiency. Global developmental delay/intellectual disability (DD/ID) speech/language delay and behavioral problems as the most affected domains was present in 44 participants, additional epilepsy 35 movement disorder 13. Treatment regimens included various combinations/dosages of creatine-monohydrate, l-ornithine, sodium benzoate protein/arginine restricted diets. The median age at treatment...

10.1016/j.ymgme.2013.10.018 article EN cc-by-nc-nd Molecular Genetics and Metabolism 2013-11-07

<h3>Objective:</h3> To describe better the motor phenotype, molecular genetic features, and clinical course of <i>GNAO1</i>-related disease. <h3>Methods:</h3> We reviewed information, video recordings, neuroimaging a newly identified cohort 7 patients with de novo missense splice site <i>GNAO1</i> mutations, detected by next-generation sequencing techniques. <h3>Results:</h3> Patients first presented in early childhood (median age presentation 10 months, range 0–48 months), wide symptoms...

10.1212/nxg.0000000000000143 article EN cc-by-nc-nd Neurology Genetics 2017-03-22

Dietary treatment is the cornerstone of therapy for phenylketonuria (PKU), but adherence to low- phenylalanine diet progressively decreases after adolescence. We designed a survey characterize dietary habits Italian adult PKU patients and identify psychological factors influencing disease perception diet. Participants (

10.1016/j.ymgmr.2018.06.007 article EN cc-by Molecular Genetics and Metabolism Reports 2018-07-11

Aromatic l-amino acid decarboxylase deficiency (AADCD) is a rare, autosomal recessive neurodevelopmental disorder characterized by impaired synthesis of dopamine, noradrenaline, adrenaline and serotonin, leading to complex syndrome motor, behavioral, autonomic symptoms. This retrospective study assessed the symptoms developmental outcome large international cohort patients with AADCD via physician and/or caregiver responses detailed, standardized questionnaire. Sixty-three (60% female; ages...

10.1002/jimd.12247 article EN cc-by-nc Journal of Inherited Metabolic Disease 2020-05-05

Abstract Constitutional heterozygous mutations of ATP1A2 and ATP1A3, encoding for two distinct isoforms the Na+/K+-ATPase (NKA) alpha-subunit, have been associated with familial hemiplegic migraine (ATP1A2), alternating hemiplegia childhood (ATP1A2/A3), rapid-onset dystonia-parkinsonism, cerebellar ataxia-areflexia-progressive optic atrophy, relapsing encephalopathy ataxia (all ATP1A3). A few reports described single individuals ATP1A2/A3 severe epilepsies. Early lethal hydrops fetalis,...

10.1093/brain/awab052 article EN Brain 2021-02-10
Marcello Scala Masashi Nishikawa Hidenori Ito Hidenori Tabata Tayyaba Khan and 92 more Andrea Accogli Laura Davids Anna Ruiz Pietro Chiurazzi Gabriella Cericola Björn Schulte Kristin G. Monaghan Amber Begtrup Annalaura Torella Michele Pinelli Anne‐Sophie Denommé‐Pichon Antonio Vitobello Caroline Racine Maria Margherita Mancardi Courtney Kiss Andrea Guerin Wendy Wu Elisabeth Gabau Vila Bryan C. Mak Julián A. Martínez-Agosto Michael B. Gorin Bugrahan Duz Yavuz Bayram Claudia M.B. Carvalho Jaime E Vengoechea David Chitayat Tiong Yang Tan Bert Callewaert Bernd Kruse Lynne M. Bird Laurence Faivre Marcella Zollino Saskia Biskup Gabrielle Brown Manish J. Butte Esteban C. Dell’Angelica Naghmeh Dorrani Emilie D. Douine Brent L. Fogel Irma Gutierrez Alden Huang Deborah Krakow Hane Lee Sandra K. Loo Bryan C. Mak Martín G. Martín Julián A. Martínez-Agosto Elisabeth McGee Stanley F. Nelson Shirley Nieves‐Rodriguez Christina G.S. Palmer Jeanette C. Papp Neil H. Parker Genecee Renteria Janet S. Sinsheimer Jijun Wan Lee-kai Wang Katherine Wesseling Perry Vincenzo Nigro Nicola Brunetti‐Pierri Giorgio Casari Gerarda Cappuccio Annalaura Torella Michele Pinelli Francesco Musacchia Margherita Mutarelli Diego Carrella Giuseppina Vitiello Valeria Capra Giancarlo Parenti Vincenzo Leuzzi Angelo Selicorni Silvia Maitz Sandro Banfi Marcella Zollino Mario Montomoli Donatelli Milani Corrado Romano Albina Tummolo Daniele De Brasi Antonietta Coppola Claudia Santoro Angela Peron Chiara Pantaleoni Raffaele Castello Stefano D’Arrigo Pasquale Striano Vincenzo Nigro Mariasavina Severino Valeria Capra Gregory Costain Koh Nagata

Abstract Variants in RAC3, encoding a small GTPase RAC3 which is critical for the regulation of actin cytoskeleton and intracellular signal transduction, are associated with rare neurodevelopmental disorder structural brain anomalies facial dysmorphism. We investigated cohort 10 unrelated participants presenting global psychomotor delay, hypotonia, behavioural disturbances, stereotyped movements, dysmorphic features, seizures musculoskeletal abnormalities. MRI revealed complex pattern...

10.1093/brain/awac106 article EN cc-by Brain 2022-03-19

Guanidinoactetate methyltransferase (GAMT) deficiency is an autosomal recessive disorder of creatine synthesis. The authors analyzed clinical, biochemical, and molecular findings in 27 patients.The collected data from questionnaires literature reports. A score including degree intellectual disability, epileptic seizures, movement was developed used to classify clinical phenotype as severe, moderate, or mild. Score biochemical were assessed before during treatment with oral substitution alone...

10.1212/01.wnl.0000234852.43688.bf article EN Neurology 2006-07-20

We report the effect on complex I function of 14484 Leber's hereditary optic neuropathy (LHON) mutation affecting ND6 subunit gene. The same gene was also reported to carry another mutation, at position 14459, associated with LHON/dystonia phenotype that induces a reduction I-specific activity and increases sensitivity product decylubiquinol. Given proximity both mutations in gene, we tested specific its myxothiazol nonylbenzoquinol, inhibitors ubiquinol site, platelet submitochondrial...

10.1002/1531-8249(199903)45:3<320::aid-ana7>3.0.co;2-l article EN Annals of Neurology 1999-03-01

Abstract No controlled studies exist regarding the pharmaceutical reduction of ataxia symptoms in telangiectasia (A‐T). In a multicenter, double‐blind, randomized, placebo‐controlled crossover trial, oral betamethasone (BETA) and placebo were compared terms their as assessed with International Cooperative Ataxia Rating Scale (ICARS). this study 13 A‐T children, reduced ICARS total score by median points intent‐to‐treat population 16 per‐protocol (ie, percent decreases 28% 31%, respectively)....

10.1002/mds.25126 article EN Movement Disorders 2012-08-23
Coming Soon ...